Trial Profile
A Study to Evaluate the Efficacy and Safety of S-1 Plus Docetaxel in Patients with Advanced Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms N-1 study
- 09 Dec 2015 New trial record